tirzepatide doses for weight loss Conversion chart dosing for Tirzepatide Weight Loss Injections |

The above studies suggest that GLP-1 can significantly reduce LFC and inflammatory response in patients with T2DM and NAFLD, and even slow down the process of liver fibrosis [115]

In recent years, stronger versions of these GLP-1s were approved to help people with overweight and obesity

If weight increases by more than 5 percent or appetite becomes difficult to manage, return to the previous higher dose

For Wegovy, follow the specific missed-dose guidance in the FDA prescribing information

Following a year of treatment, the average weight reduction was 3.6 percent among participants who discontinued their treatment early, compared to 6.8 percent for those who discontinued their treatment late

This story first appeared on MM+M.